Wedbush’s initiation is a mildly bullish signal from a moderately accurate firm, aligning with strong consensus but not offering contrarian edge. Watch for institutional follow-through ahead of June 9 earnings; long exposure is justified but not urgent.
Price Chart
Executive Summary
Wedbush initiated coverage on Oracle (ORCL) with an Outperform rating and $225 price target, implying 27.6% upside from the current $176.28. The firm’s 57% accuracy rate (917/1604 calls) is above average but below top-tier peers. Consensus is strongly bullish: 66.7% Buy-rated (40 of 60 analysts), with a mean PT of $243.71. Recent analyst momentum shows 1 upgrade and 0 downgrades in the past 30 days. EPS estimates are trending upward, with 3 revisions higher in the last 30 days for +1y EPS. Institutional activity is mixed: Norges Bank and Two Sigma initiated large new positions, while Causeway and Mawer fully exited. Insider selling totaled $2.64M on April 16. Congressional trades show minor buys and sells. Earnings due June 9 — within 45 days — add timing relevance. Wedbush’s call aligns with bullish consensus but is below the median PT of $220.
Impact Score
Consensus & Targets
Of 60 total analysts, 40 rate ORCL a Buy (66.7%), 10 Hold (16.7%), and 1 Sell (1.7%). The consensus direction is strongly bullish, with no recent downgrades. This initiation aligns with the prevailing bullish sentiment.
The consensus mean price target is $243.71, median $220, high $400, low $155. ORCL trades at $176.28, implying 38.4% upside to the mean and 24.8% to the median. Wedbush’s $225 PT is 7.3% above the median and 7.4% below the mean, placing it in the upper tier of targets but not extreme.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-04-24 | Wedbush | initiate | Outperform | $225.00 |
| 2026-04-23 | Morgan Stanley | maintain | Equal-Weight | $207.00 |
| 2026-04-07 | Stephens & Co. | reiterate | Equal-Weight | $254.00 |
| 2026-03-16 | Mizuho | maintain | Outperform | $320.00 |
| 2026-03-13 | Guggenheim | reiterate | Buy | $400.00 |
| 2026-03-12 | Citigroup | maintain | Buy | $320.00 |
| 2026-03-11 | Stifel | maintain | Buy | $220.00 |
| 2026-03-11 | Barclays | maintain | Overweight | $240.00 |
| 2026-03-11 | BMO Capital | maintain | Outperform | $200.00 |
| 2026-03-11 | TD Cowen | reiterate | Buy | $250.00 |
In the past 30 days, ORCL saw 1 upgrade and 0 downgrades. EPS estimates are rising: +1y EPS revised up 3 times and down once in the past 30 days, current estimate $7.98, up from $7.97. Near-term estimates show minor downward drift in 0q EPS, but full-year 0y EPS also revised up twice, down zero.
Firm Track Record — Wedbush
Wedbush accuracy: 57% on 1604 calls | avg return: 7.2%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Oppenheimer | 100% | 2/2 | 16.8% | top tier |
| WestPark Capital | 100% | 2/2 | 50.7% | top tier |
| Keybanc | 71% | 5/7 | 11.9% | top tier |
| Deutsche Bank | 67% | 2/3 | 13% | top tier |
| Morgan Stanley | 67% | 6/9 | 14.9% | top tier |
| UBS | 64% | 7/11 | 5.6% | top tier |
| Guggenheim | 64% | 7/11 | 12.2% | top tier |
| Jefferies | 63% | 5/8 | 9.5% | top tier |
| B of A Securities | 63% | 5/8 | 6.8% | top tier |
| Stifel | 63% | 5/8 | 7.7% | top tier |
Wedbush has a 57% accuracy rate (917 correct out of 1,604 rated calls) with an average return of 7.2%, placing it above average but below top-tier firms. Oppenheimer (100%, 2/2), WestPark (100%, 2/2), and Keybanc (71%, 5/7) lead in accuracy. Morgan Stanley (67%, 6/9) and Mizuho (57%, 4/7) are peers with stronger returns.
Earnings Estimates
Next earnings: Jun 9, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1q | $1.68 | $1.51 — $1.84 | $19.0B | ↑1 ↓0 |
| 0y | $7.46 | $6.59 — $7.69 | $67.2B | ↑1 ↓0 |
| +1y | $7.98 | $6.16 — $9.26 | $88.3B | ↑1 ↓0 |
| 0q | $1.96 | $1.76 — $2.03 | $19.1B | ↑0 ↓0 |
Cross-Platform Signals
Institutional activity is divergent: Norges Bank ($4.34B new) and Two Sigma ($151.7M, +1369.6%) initiated or expanded positions, while Causeway and Mawer exited entirely. Renaissance Technologies started a new $323K stake. Insider activity shows one sell: Stuart Levey sold $2.64M on April 16. Congressional trades show two buys and one sell, all in minimal ranges. Short interest is elevated at 13.4M shares, but short ratio of 60.4% reflects high off-exchange volume rather than pure bearishness.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 8-K | $144.79 $148.56 | ▲ +2.60% | ▲ +2.50% | $142.19 (−1.80%) |
Aug 25, 2026 5w ago | GOVT-CONTRACT | $144.76 $141.32 | ▼ −2.38% | ▼ −1.84% | $142.19 (−1.78%) |
Jul 20, 2026 10w ago | ANALYST-UPGRADE | $121.38 $114.99 | ▲ +5.26% | ▲ +4.84% | $142.19 (−17.14%) |
Jun 24, 2026 14w ago | 144 | $152.46 $142.50 | ▼ −6.53% | ▼ −8.09% | $142.19 (−6.74%) |
Jun 10, 2026 16w ago | 8-K | $54.86 $54.20 | ▼ −1.20% | ▼ −2.42% | $142.19 (+159.19%) |
May 12, 2026 20w ago | 8-K | $56.38 $54.07 | ▼ −4.10% | ▼ −2.94% | $142.19 (+152.20%) |
Apr 24, 2026 22w ago | ANALYST-UPGRADE | $173.27 $161.39 | ▼ −6.85% | ▼ −7.76% | $142.19 (−17.94%) |
Apr 21, 2026 23w ago | Court Ruling | $181.17 $165.96 | ▼ −8.40% | ▼ −9.48% | $142.19 (−21.52%) |
Apr 6, 2026 25w ago | 8-K | $45.02 $47.84 | ▲ +6.26% | ▲ +2.13% | $142.19 (+215.84%) |
Mar 30, 2026 26w ago | Court Ruling | $138.79 $142.81 | ▲ +2.90% | ▼ −1.40% | $142.19 (+2.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access